key: cord-1009999-63sjus3c
authors: Lv, Yanling; Chen, Liangkai; Liang, Xiaoling; Liu, Xiaohui; Gao, Ming; Wang, Qiang; Wei, Qing; Liu, Liegang
title: Association between iron status and the risk of adverse outcomes in COVID-19
date: 2020-12-09
journal: Clin Nutr
DOI: 10.1016/j.clnu.2020.11.033
sha: 8130df770cd68c7fcdc98e42b771aee087688e93
doc_id: 1009999
cord_uid: 63sjus3c

Background & Aims Iron is an essential trace element to almost all organism, and the delicate balance between host defend system and viral proliferation plays an important role in infective conditions. While the association of the iron metabolism with the prognosis of COVID-19 remains poorly understood. We aimed to estimate the associations of systemic iron metabolism parameters with the severity and risks of adverse outcomes in COVID-19. Methods In this retrospective cohort study, we included 158 confirmed COVID-19 patients in Tongji Hospital, Wuhan, China (27 January to 5 April, 2020). Demographic data, comorbidities, laboratory examinations, treatments, and clinical outcomes were all collected. Multivariable Poisson regression was used to estimate the association of iron parameter levels with the severity and risks of adverse outcomes in COVID-19 patients. Results We identified 60 (38%) severe cases in 158 COVID-19 patients. The median age was 63 years (interquartile range [IQR]: 54–73) and the median length of hospital stay was 28 days (IQR: 17–40). After adjusting for age, sex, IL-6, and pre-existing comorbidities, all iron parameters were associated with the severity of COVID-19 with adjusted risk ratio of 0.42 [95% CI: 0.22–0.83], 4.38 [95% CI: 1.86–10.33], 0.19 [95% CI: 0.08–0.48], and 0.25 [95% CI: 0.10–0.58] for serum iron, ferritin, transferrin, and total iron-binding capacity, respectively. These iron indices were also related to the risk of ARDS, coagulopathy, acute cardiac injury, acute liver injury, and acute kidney injury in COVID-19 patients and high cytokine concentrations. Conclusions Patients with low serum iron status likely suffered from severe condition and multiple–organ injury in COVID-19. The iron metabolism parameters might be risk factors and clinical biomarkers for COVID-19 prognosis.

Coronavirus disease 2019 , caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a pandemic (1) . As of September 14, 2020, more than 29 million cases and 920,000 deaths are confirmed over 200 countries, which causes a burden to the global medical system. Acute respiratory distress syndrome (ARDS) and multiorgan failure are major causes of mortality in COVID-19 patients (2) , and the host excessive inflammation response or "cytokine storm" is part of the reason for ARDS and multiorgan failure (3, 4) .

Iron is required for various fundamental biological processes ranging from DNA synthesis to ATP generation in human and pathogens (5) . After viral invasion, the rapid proliferation puts iron in the center of a competition between host cells and virus, indicating that iron status may affect viral replication and damage to host cells (6) . As a β-coronavirus, SARS-CoV-2 attacks host cells through angiotensin-converting enzyme 2 and causes damages to almost all tissue and organs, and the immune system plays an important role in the viral pathogenic mechanism (7) . Iron homeostasis is crucial for the host immune defense system, because the property of gaining and losing electrons results in the generation of superoxide anions, and its content in macrophage regulates the production of pro-inflammatory cytokines (8) .

The association of iron status with COVID-19 prognosis has been preliminarily explored. A previous study in SARS found that serum iron level decreased in J o u r n a l P r e -p r o o f 6 confirmed patients (9) , and studies on COVID-19 found that low serum iron level was an independent risk factor for the severity of hypoxemic respiratory failure and death in COVID-19 patients (10, 11) . High concentration of serum ferritin was also found to be associated with poor outcomes in COVID-19 patients (12) . However, recent studies were descriptive case series or had a relatively small sample size. In the present study, we aimed to depict the systemic iron status in COVID-19 patients and assess the association between the iron metabolism parameters and poor prognosis of COVID-19.

This retrospective cohort study was conducted in Tongji Hospital, which was one of the designated centers for COVID-19 treatment in Wuhan, China. In this study, we included 169 patients with iron metabolism indices. After excluding patients who were pregnant, younger than 20 years, and possessed acute lethal organ injury on admission or hematological diseases, 158 patients were included in the final analysis.

All patients were confirmed of SARS-CoV-2 infection according to the guidance of the National Health Commission of China and the World Health Organization (13, 14) . All enrolled patients were followed up until death or discharge. The informed consent was waived because of the urgent need to collect data on the newly emerged pathogen. Among all comorbidities, hypertension was the commonest (n = 61, 39%). Compared with non-severe patients, severe patients had higher levels of pro-inflammatory cytokines at baseline, including interleukin-6, interleukin-8, interleukin-2 receptor, and tumor necrosis factor-α. The levels of infection biomarkers such as high-sensitivity C-reactive protein and procalcitonin were higher in severe patients. As for lymphocytes, we found that cell counts (including lymphocytes, total T cells, CD4+ T cells, CD8+ T cells, total B cells, and natural killer cells) at admission were lower in severe patients, but subset proportions had no significant difference in the two groups of patients. At the end of follow-up, five (3%) deaths occurred in severe patients.

During hospitalization, the most common complication in all patients was ARDS (n = 64, 41%), followed by ACI (n = 44, 28%) and ALI (n = 43, 27%), then coagulopathy (n = 33, 21%), AKI (n = 22, 14%), DIC (n = 8, 5%), and septic shock (n = 5, 3%). The incidences of these undesirable outcomes were augmented in severe patients compared with non-severe patients (all P < 0.001).

Adjusted mean of Adjusted mean of Adjusted mean of Adjusted mean of the the the the baseline baseline baseline baseline s s s serum erum erum erum iron iron iron iron metabolism metabolism metabolism metabolism parameters parameters parameters parameters by by by by outcomes outcomes outcomes outcomes J o u r n a l P r e -p r o o f 11 The correlation between iron metabolism parameters levels in our study was shown in Figure 1 . We compared the iron metabolism indices of COVID-19 patients who suffered from different adverse outcomes with patients who did not progress to the relevant outcome to assess their iron status. After adjusting for sex, age, and comorbidities (including hypertension, diabetes, cardiac disease, cerebrovascular disease, chronic pulmonary disease, chronic kidney disease, chronic liver disease, and tumor), we found that the adjusted mean of the serum iron metabolism parameters at baseline differed significantly in patients with or without adverse outcomes (Table 1 ). In particular, severe patients had a higher serum ferritin level and lower serum levels of iron, transferrin, total iron-binding capacity, and unsaturated iron-binding capacity than those in non-severe condition. The iron metabolism parameters also differed in patients with or without multiple-organ injury. The serum level of iron was lower in patients who suffered from ARDS, coagulopathy, ACI, AKI, DIC, and septic shock during hospitalization, and ICU/IMV/death (P = 0.003 for AKI, P = 0.005 for septic shock, and P < 0.001 for others). Similarly, we found that serum concentration of transferrin and total iron-binding capacity value were lower in patients with adverse outcomes (all P < 0.05), and unsaturated iron-binding capacity value was lower in patients who suffered from ARDS, coagulopathy, ALI, DIC, and septic shock during follow-up (all P < 0.05). However, serum ferritin was higher in those who had ARDS, coagulopathy, ACI, ALI, DIC, and septic shock, and J o u r n a l P r e -p r o o f 12 ICU/IMV/death (P = 0.016 for coagulation disorders and P < 0.001 for the rest). In addition, the serum level of TSAT was lower in patients with ACI, AKI, and DIC, whereas sTfR was not significantly different in all groups.

Baseline s Baseline s Baseline s Baseline serum levels of erum levels of erum levels of erum levels of the the the the iron metabolism parameters were associated with iron metabolism parameters were associated with iron metabolism parameters were associated with iron metabolism parameters were associated with various various various various a a a adverse outcomes dverse outcomes dverse outcomes dverse outcomes

In the multivariable Poisson regression model, the baseline serum levels of the iron metabolism parameters were significantly associated with the risk of various adverse outcomes ( β-Coefficients and 95% CI of all iron metabolism indicators with these indices were presented in Table 4 . After log-transforming and adjusting for age, sex, and pre-existing comorbidities, we found that the serum iron status was significantly associated with the expression of pro-inflammatory cytokines. Serum iron was negatively related to the levels of IL-6, IL-8, and IL-2R. In addition, transferrin, TIBC, and UIBC were negatively associated with IL-6, IL-8, IL-2R, and TNF-α (all P <0.05).

As an inflammatory indicator, serum ferritin was positively related to high levels of IL-6, IL-8, IL-2R, and TNF-α (all P <0.01). The dose-response relationship between systemic iron status and IL-6 concentration was shown in Figure 2 , and the association of iron indices with IL-8 and IL-2R was presented in Supplemental Figure   2 and 3. In our study, serum TSAT and sTfR values were not associated with cytokine content.

In this study, we systemically described iron status in severe and non-severe patients and reported a significant association of iron metabolism disorders with COVID-19

severity and the risk of various adverse outcomes. In particular, increased serum J o u r n a l P r e -p r o o f 15 ferritin, decreased serum iron, transferrin, TIBC, and UIBC were associated with the increased risk of severe COVID-19, ARDS, and acute organ injuries. We did not estimate the associations of the iron metabolism parameters with DIC, septic shock and death, because the low incidence of these outcomes would limit the statistical power. No significant relations were found for TSAT and sTfR. Based on previous reports, this longitudinal study was the first to systemically investigate the association of iron metabolism parameters with the risk of various adverse COVID-19 outcomes.

Former studies have indicated a U-shape of iron status and the risk of infection (22) .

However, whether the iron metabolism parameters are risk factors for COVID-19

prognosis remains poorly understood. A previous study in Austria found that ferritin and transferrin were both associated with the risk for ICU admission in COVID-19

patients, and no significant relations were found in iron and other indices (23) . This study indicated the relation between iron metabolism and the undesirable outcome of COVID-19, whereas the association with specific comorbidities warrants further investigation. In our study, we found high serum iron level was associated with disease severity in COVID-19 patients. A case series of 30 ICU patients in UK found that serum iron was low in severe patients and related to the severity of hypoxemic 

Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive care medicine

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities. The Lancet Respiratory medicine

COVID-19: consider cytokine storm syndromes and immunosuppression

Viral infection and iron metabolism

Hepcidin and the iron-infection axis

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Iron homeostasis in host defence and inflammation

Serum Iron Level as a Potential Predictor of Coronavirus Disease 2019 Severity and Mortality: A Retrospective Study. Open forum infectious diseases

Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19

C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Therapeutic advances in respiratory disease

Clinical management of severe acute respiratory infection when novel coronavirus ( 2019-nCoV) infection is suspected: interim guidance

Geneva: World Health Organization

National Health Commission of the People's Republic of China

Acute respiratory distress syndrome: the Berlin Definition

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19: Abnormal liver function tests

KDIGO clinical practice guidelines for acute kidney injury

Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Association of iron status with the risk of bloodstream infections: results from the prospective population-based HUNT Study in Norway

Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection

Association of inflammatory markers with the severity of COVID-19: A meta-analysis. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases